Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains

BACKGROUND/AIMS: Chronic hepatitis B infection is a common cause of secondary membranous nephropathy (MN) in endemic areas. Lamivudine treatment improves renal outcome in patients with hepatitis B virus-associated MN (HBV-MN), but prolonged use leads to the emergence of lamivudine-resistant variants...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, In O, Hong, Yu Ah, Park, Hoon Suk, Choi, Sun Ryoung, Chung, Byung Ha, Park, Cheol Whee, Yang, Chul Woo, Kim, Yong Soo, Choi, Bum Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529240/
https://www.ncbi.nlm.nih.gov/pubmed/23269882
http://dx.doi.org/10.3904/kjim.2012.27.4.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529240/
https://www.ncbi.nlm.nih.gov/pubmed/23269882
http://dx.doi.org/10.3904/kjim.2012.27.4.411

Ejemplares similares